Loading…
This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Thursday, April 28 • 6:00am - 7:30am
IMBRUVICA® Single-Agent Therapy for Previously Treated Chronic Lymphocyctic Leukemia and Chronic Lymphocytic Leukemia with 17p deletion: A Support and Education Resource for Nursing Professionals*

Sign up or log in to save this to your schedule and see who's attending!

Please join us for a Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc. presentation of IMBRUVICA® (ibrutinib). Karolina Faysman, NP, RN, MSN, ONP, from UCLA Medical Center, will discuss IMBRUVICA®.


Sponsored by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc